MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Molecular Clues to Breast Cancer

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Molecular Clues to Breast Cancer




New insights into the role of estrogen receptor in mammary gland development may help researchers better understand the molecular origin of breast cancer, as per new research from the University of Cincinnati (UC).

About a decade ago, U.S. researchers at the National Institutes of Health (NIH) developed a standard estrogen receptor (ER) gene knock-out mouse model to study the estrogen receptor's role in human diseases.

"Unfortunately, because these mice lacked mammary glands as a consequence of genetic manipulation, using this model to study the relationship between the estrogen receptor and breast cancer proved ineffective," explains Sohaib Khan, PhD, professor of cell and cancer biology at UC.



Molecular Clues to Breast Cancer

"Knocking out the estrogen receptor gene for the entire genome, as the NIH researchers did, doesn't just affect the function of the receptor in all estrogen-responsive organs. It also creates an imbalance in the body's circulating sex hormone levels, which could affect other physiological functions," Khan adds. "An alternative model was clearly needed to study the intricacies of estrogen receptors involvement in this disease".

Estrogen receptor is a cellular protein that binds with the hormone estrogen and facilitates action in different parts of the body, including the mammary gland. Research has shown that about 70 percent of patients with breast cancer have estrogen receptor-positive breast cancer, meaning their tumors will have some beneficial response to anti-estrogen drugs like tamoxifen (ta-MOX'-ee-fen, marketed as Nolvodex).

After two years of work, Khan says his team has developed a knock-out mouse model that will allow researchers to study the role of estrogen receptor in specific organs (for example, mammary glands) without affecting estrogen-signaling throughout the rest of its body.

Khan used what is called a "conditional knock-out technique" to develop a new mouse model that retains estrogen receptor in all tissues except mammary tissue, allowing researchers to study the receptor's role in breast development and breast cancer.

Using this model, Khan's team observed that knocking out the gene only in mammary tissue resulted in abnormalities that compromised milk production in the nursing female. This suggests that estrogen expression is essential for normal duct development during puberty, pregnancy and lactation.

Khan and his colleagues report the creation of this model and its potential implications in an early online edition of the Proceedings of the National Academy of Sciences on Sept. 4, 2007, followed by the print issue Sept. 11, 2007. The study directly refutes prior research, which suggests that estrogen receptor in epithelial cells was not essential to normal mammary gland development.

Mammary tissue is made up of two cell types-stromal cells, which give the tissue structure, and epithelial cells, which make up the lining of the mammary gland and become malignant in the majority of breast cancers.

Unlike other organs in the body, the mammary glands develop after birth in response to increases in circulating hormones. This triggers growth of a network of branched ducts throughout the breast tissue that do not change again until a woman becomes pregnant.

"Even though the relationship between the estrogen receptor and breast cancer is well established, we still know very little about the receptor's mechanism of action," explains Khan, corresponding author of the study. "Unless we study those mechanisms more closely, improved strategies for breast cancer therapys will not be possible".

Premenopausal women with breast cancer are currently given five years of tamoxifen, a drug that blocks the estrogen receptor action in cancer cells, to prevent recurrence. Studies have shown that the drug reduces recurrence in 40 percent of the women who take it, but Khan says a number of women eventually develop resistance to the drug.

Using this unique mouse model, UC scientists are currently collaborating with researchers at Dana Farber Cancer Institute/Harvard Medical School to understand the relationship between estrogen-signaling and oncogene-mediated breast cancer development. Future findings from these studies could help researchers better understand the molecular origin of breast cancer and develop new drugs to more effectively treat it.


Posted by: Janet    Source




Did you know?
New insights into the role of estrogen receptor in mammary gland development may help researchers better understand the molecular origin of breast cancer, as per new research from the University of Cincinnati (UC). About a decade ago, U.S. researchers at the National Institutes of Health (NIH) developed a standard estrogen receptor (ER) gene knock-out mouse model to study the estrogen receptor's role in human diseases.

Medicineworld.org: Molecular Clues to Breast Cancer

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.